ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · Real-Time Price · USD

12.99

-0.25 (-1.89%)

Aug 31, 2026, 4:00 PM EDT - Market closed

ORIC Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	33.78	33.19	28.82	25.61	25.09	22.01
Research & Development	122.36	109.82	114.07	85.17	61.68	56.86
Operating Expenses	156.14	143	142.9	110.78	86.77	78.87
Operating Income	-156.14	-143	-142.9	-110.78	-86.77	-78.87
Interest & Investment Income	15.79	13.54	15.05	10.08	2.65	0.14
Other Non Operating Income (Expenses)	-	-	-	-	-	0.02
EBT Excluding Unusual Items	-140.35	-129.47	-127.85	-100.7	-84.12	-78.72
Pretax Income	-140.35	-129.47	-127.85	-100.7	-89.12	-78.72
Net Income	-140.35	-129.47	-127.85	-100.7	-89.12	-78.72
Net Income to Common	-140.35	-129.47	-127.85	-100.7	-89.12	-78.72
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	104	88	70	51	40	38
Shares Outstanding (Diluted)	104	88	70	51	40	38
Shares Change	43.06%	25.91%	35.52%	29.74%	4.48%	72.97%
EPS (Basic)	-1.35	-1.47	-1.83	-1.96	-2.25	-2.07
EPS (Diluted)	-1.35	-1.47	-1.83	-1.96	-2.25	-2.07
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-112.26	-111.68	-113.85	-86.54	-77.22	-60.48
Free Cash Flow Per Share	-1.08	-1.27	-1.63	-1.68	-1.95	-1.59
EBITDA	-155	-141.78	-141.79	-109.75	-85.8	-77.97
D&A For EBITDA	1.14	1.22	1.11	1.03	0.97	0.9
EBIT	-156.14	-143	-142.9	-110.78	-86.77	-78.87

SEC Filings: 10-K · 10-Q